XML 96 R85.htm IDEA: XBRL DOCUMENT v3.25.2
Supplemental Consolidating Data - Schedule of Cash Flows (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:            
Net income $ 105,745 $ 130,797 $ 215,406 $ 232,233 $ 236,542 $ 447,639
Adjustments to reconcile Net income to Net cash provided by operating activities:            
Depreciation and amortization         82,129 80,376
Amortization of deferred loan origination costs         32,489 36,466
Amortization of financing origination fees         6,630 6,793
Income related to long-term employee benefits         (27,526) (26,143)
Employee benefit plan contributions and payments         (3,256) (2,593)
Stock compensation expense         17,407 28,995
Net change in wholesale finance receivables related to sales         (145,174) (388,030)
Provision for credit losses         103,072 117,040
Deferred income taxes         13,856 146
Other, net         1,592 14,965
Changes in current assets and liabilities:            
Accounts receivable, net         (66,851) (65,927)
Finance receivables – accrued interest and other         4,999 2,759
Inventories, net         142,996 235,539
Accounts payable and accrued liabilities         136,098 64,166
Other current assets         (25,511) 25,451
Total adjustments         272,950 130,003
Net cash provided by operating activities         509,492 577,642
Cash flows from investing activities:            
Capital expenditures         (65,560) (87,835)
Origination of finance receivables         (1,765,951) (2,095,952)
Collections on finance receivables         1,740,966 1,786,964
Other investing activities         691 (206)
Net cash used by investing activities         (89,854) (397,029)
Cash flows from financing activities:            
Proceeds from issuance of medium-term notes         647,088 495,856
Repayments of medium-term notes         (700,000) 0
Proceeds from securitization debt         497,790 547,618
Repayments of securitization debt         (584,153) (506,489)
Borrowings of asset-backed commercial paper         155,000 351,429
Repayments of asset-backed commercial paper         (145,379) (125,654)
Net decrease in unsecured commercial paper         (135,902) (379,743)
Net increase (decrease) in deposits         (13,073) 56,007
Dividends paid         (44,756) (47,359)
Repurchase of common stock         (93,140) (209,675)
Other financing activities         6 8
Net cash (used) provided by financing activities         (416,519) 181,998
Effect of exchange rate changes on cash, cash equivalents and restricted cash         12,375 (10,821)
Net increase in cash, cash equivalents and restricted cash         15,494 351,790
Cash, cash equivalents and restricted cash:            
Cash, cash equivalents and restricted cash, beginning of period   1,740,854   1,648,811 1,740,854 1,648,811
Net (decrease) increase in cash, cash equivalents and restricted cash         15,494 351,790
Cash, cash equivalents and restricted cash, end of period 1,756,348   2,000,601   1,756,348 2,000,601
Reportable Legal Entities | Non-Financial Services Entities            
Cash flows from operating activities:            
Net income 53,807   162,731   136,346 355,095
Adjustments to reconcile Net income to Net cash provided by operating activities:            
Depreciation and amortization         77,352 75,768
Amortization of deferred loan origination costs         0 0
Amortization of financing origination fees         364 360
Income related to long-term employee benefits         (27,526) (26,143)
Employee benefit plan contributions and payments         (3,256) (2,593)
Stock compensation expense         16,246 27,896
Net change in wholesale finance receivables related to sales         0 0
Provision for credit losses         0 0
Deferred income taxes         11,955 2,145
Other, net         (18,648) 13,339
Changes in current assets and liabilities:            
Accounts receivable, net         (282,732) (233,698)
Finance receivables – accrued interest and other         0 0
Inventories, net         142,996 235,539
Accounts payable and accrued liabilities         95,281 48,395
Other current assets         6,156 9,347
Total adjustments         18,188 150,355
Net cash provided by operating activities         154,534 505,450
Cash flows from investing activities:            
Capital expenditures         (65,330) (87,050)
Origination of finance receivables         0 0
Collections on finance receivables         0 0
Other investing activities         691 (1,206)
Net cash used by investing activities         (64,639) (88,256)
Cash flows from financing activities:            
Proceeds from issuance of medium-term notes         0 0
Repayments of medium-term notes          
Proceeds from securitization debt         0 0
Repayments of securitization debt         0 0
Borrowings of asset-backed commercial paper         0 0
Repayments of asset-backed commercial paper         0 0
Net decrease in unsecured commercial paper         0 0
Net increase (decrease) in deposits         0 0
Dividends paid         (44,756) (47,359)
Repurchase of common stock         (93,140) (209,675)
Other financing activities         6 8
Net cash (used) provided by financing activities         (137,890) (257,026)
Effect of exchange rate changes on cash, cash equivalents and restricted cash         9,678 (10,595)
Net increase in cash, cash equivalents and restricted cash         (38,317) 149,573
Cash, cash equivalents and restricted cash:            
Cash, cash equivalents and restricted cash, beginning of period   1,105,663   1,127,400 1,105,663 1,127,400
Net (decrease) increase in cash, cash equivalents and restricted cash         (38,317) 149,573
Cash, cash equivalents and restricted cash, end of period 1,067,346   1,276,973   1,067,346 1,276,973
Reportable Legal Entities | Financial Services Entities            
Cash flows from operating activities:            
Net income 52,192   52,771   100,243 92,533
Adjustments to reconcile Net income to Net cash provided by operating activities:            
Depreciation and amortization         4,777 4,608
Amortization of deferred loan origination costs         32,489 36,466
Amortization of financing origination fees         6,266 6,433
Income related to long-term employee benefits         0 0
Employee benefit plan contributions and payments         0 0
Stock compensation expense         1,161 1,099
Net change in wholesale finance receivables related to sales         0 0
Provision for credit losses         103,072 117,040
Deferred income taxes         2,025 (1,445)
Other, net         20,195 1,637
Changes in current assets and liabilities:            
Accounts receivable, net         0 0
Finance receivables – accrued interest and other         4,999 2,759
Inventories, net         0 0
Accounts payable and accrued liabilities         230,797 171,199
Other current assets         (10,497) 9,589
Total adjustments         395,284 349,385
Net cash provided by operating activities         495,527 441,918
Cash flows from investing activities:            
Capital expenditures         (230) (785)
Origination of finance receivables         (3,203,305) (4,210,218)
Collections on finance receivables         3,037,751 3,531,504
Other investing activities         0 0
Net cash used by investing activities         (165,784) (679,499)
Cash flows from financing activities:            
Proceeds from issuance of medium-term notes         647,088 495,856
Repayments of medium-term notes         (700,000)  
Proceeds from securitization debt         497,790 547,618
Repayments of securitization debt         (584,153) (506,489)
Borrowings of asset-backed commercial paper         155,000 351,429
Repayments of asset-backed commercial paper         (145,379) (125,654)
Net decrease in unsecured commercial paper         (135,902) (379,743)
Net increase (decrease) in deposits         (13,073) 56,007
Dividends paid         0 0
Repurchase of common stock         0 0
Other financing activities         0 1,000
Net cash (used) provided by financing activities         (278,629) 440,024
Effect of exchange rate changes on cash, cash equivalents and restricted cash         2,697 (226)
Net increase in cash, cash equivalents and restricted cash         53,811 202,217
Cash, cash equivalents and restricted cash:            
Cash, cash equivalents and restricted cash, beginning of period   635,191   521,411 635,191 521,411
Net (decrease) increase in cash, cash equivalents and restricted cash         53,811 202,217
Cash, cash equivalents and restricted cash, end of period 689,002   723,628   689,002 723,628
Consolidating Adjustments            
Cash flows from operating activities:            
Net income (254)   (96)   (47) 11
Adjustments to reconcile Net income to Net cash provided by operating activities:            
Depreciation and amortization         0 0
Amortization of deferred loan origination costs         0 0
Amortization of financing origination fees         0 0
Income related to long-term employee benefits         0 0
Employee benefit plan contributions and payments         0 0
Stock compensation expense         0 0
Net change in wholesale finance receivables related to sales         (145,174) (388,030)
Provision for credit losses         0 0
Deferred income taxes         (124) (554)
Other, net         45 (11)
Changes in current assets and liabilities:            
Accounts receivable, net         215,881 167,771
Finance receivables – accrued interest and other         0 0
Inventories, net         0 0
Accounts payable and accrued liabilities         (189,980) (155,428)
Other current assets         (21,170) 6,515
Total adjustments         (140,522) (369,737)
Net cash provided by operating activities         (140,569) (369,726)
Cash flows from investing activities:            
Capital expenditures         0 0
Origination of finance receivables         1,437,354 2,114,266
Collections on finance receivables         (1,296,785) (1,744,540)
Other investing activities         0 1,000
Net cash used by investing activities         140,569 370,726
Cash flows from financing activities:            
Proceeds from issuance of medium-term notes         0 0
Repayments of medium-term notes          
Proceeds from securitization debt         0 0
Repayments of securitization debt         0 0
Borrowings of asset-backed commercial paper         0 0
Repayments of asset-backed commercial paper         0 0
Net decrease in unsecured commercial paper         0 0
Net increase (decrease) in deposits         0 0
Dividends paid         0 0
Repurchase of common stock         0 0
Other financing activities         0 (1,000)
Net cash (used) provided by financing activities         0 (1,000)
Effect of exchange rate changes on cash, cash equivalents and restricted cash         0 0
Net increase in cash, cash equivalents and restricted cash         0 0
Cash, cash equivalents and restricted cash:            
Cash, cash equivalents and restricted cash, beginning of period   $ 0   $ 0 0 0
Net (decrease) increase in cash, cash equivalents and restricted cash         0 0
Cash, cash equivalents and restricted cash, end of period $ 0   $ 0   $ 0 $ 0